IntelGenx Technologies Corp.
IGXTDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001098880
IntelGenx Technologies Corp. was delisted in 2024; its insiders filed their last Form 4 on May 3, 2024; 1 institution reported holding it in 13F filings for Q1 2024, worth $414 in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by IntelGenx Technologies Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for IntelGenx Technologies Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| ATAI Life Sciences AG | 10% Owner | – | May 3, 2024 | 0 |
| ATAI Life Sciences N.V. | 10% Owner | – | May 3, 2024 | 0 |
| Zerbe Horst G | Director | 368,064 | Jan 31, 2024 | 0 |
| Melchers Bernd Josef | Director | – | Jan 31, 2024 | 0 |
| Godin Andre | President and CFO | 308,399 | Jan 31, 2024 | 0 |
| Mayr Clemens | Director | – | Jan 31, 2024 | 0 |
| Paiement Nadine | VP R & D of IntelGenx Corp. | – | Jan 31, 2024 | 0 |
| Nawacki Mark | Director | – | Jan 31, 2024 | 0 |
| Kenny Tommy | SVP IP Legal Affairs Subsid | 138,500 | Jan 31, 2024 | 0 |
| Kalayajian Karen | VP, Finance & Admin of Subs. | – | Jan 31, 2024 | 0 |
| Gorham Dwight | CEO | – | Jan 31, 2024 | 0 |
| Pourhassan Zenoz Nina | VP, Quality Operations of Subs | – | Jan 31, 2024 | 0 |
| Zerbe Ingrid | Corporate Secretary | 685,238 | Jan 31, 2023 | 0 |
| Matzen Dana | VP Business & Corp. Dev | 75,000 | Jan 31, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 (view filing)9:36 PM ET | Nov 28, 2023 | 105 daysLate | ATAI Life Sciences AG and 1 other10% Owner | PPurchase | +8.11M | – | – | –16.1M after | Derivative2 lots |
| Sep 5, 2023 (view filing)9:00 PM ET | Aug 31 | 5 days | ATAI Life Sciences AG and 1 other10% Owner | PPurchase | +24.0M | – | – | –12.0M after | Derivative2 lots |
| Oct 3, 2022 (view filing)8:47 AM ET | Sep 30 | 3 days | Zerbe Horst GChief Executive Officer | PPurchaseCommon Stock, 0.00001 p.V | +19.0K | $0.1251 | +$2.38K | +5.4%368.1K after | 2 lots |
| Oct 3, 2022 (view filing)8:12 AM ET | Sep 29 | 4 days | Godin AndrePresident and CFO | PPurchaseCommon Stock, 0.00001 p.V. | +5.00K | $0.124 | +$620 | +1.6%308.4K after | |
| Sep 29, 2022 (view filing)8:01 AM ET | Sep 27-28 | 2 days | Godin AndrePresident and CFO | PPurchaseCommon Stock, 0.00001 p.V. | +10.0K | $0.1346 | +$1.35K | +3.4%303.4K after | 2 lots |
| Sep 28, 2022 (view filing)8:00 AM ET | Sep 26 | 2 days | Kenny TommyVP IP Legal Affairs-Subsidiary | PPurchaseCommon Stock, 0.00001 p.V. | +19.0K | $0.135 | +$2.56K | +15.9%138.5K after | |
| Sep 26, 2022 (view filing)8:27 AM ET | Sep 22 | 4 days | Kenny TommyVP IP Legal Affairs-Subsidiary | PPurchaseCommon Stock, 0.00001 p.V. | +23.5K | $0.145 | +$3.41K | +27.3%109.5K after | |
| Sep 26, 2022 (view filing)8:27 AM ET | Sep 22-23 | 4 days | Kenny TommyVP IP Legal Affairs-Subsidiary | PPurchaseCommon Stock, 0.00001 p.V | +10.0K | $0.1472 | +$1.47K | +9.1%119.5K after | 2 lots |
| Sep 22, 2022 (view filing)4:15 PM ET | Sep 21 | 1 day | Godin AndrePresident and CFO | PPurchaseCommon Stock, 0.00001 p.V | +20.0K | $0.134 | +$2.68K | +7.3%293.4K after | |
| Sep 22, 2022 (view filing)9:26 AM ET | Sep 21 | 1 day | Matzen DanaVP BD & Corp.Dev.of Subsidiary | PPurchaseCommon Stock, 0.00001 p.V. | +25.0K | $0.138 | +$3.45K | +50.0%75.0K after | |
| Mar 31, 2022 (view filing)4:00 PM ET | Mar 30 | 1 day | Matzen DanaVP BD & Corp.Dev.of Subsidiary | PPurchaseCommon Stock, 0.00001 p.V. | +25.0K | $0.265 | +$6.63K | +100.0%50.0K after |